Shares of Option Care Health, Inc. (NASDAQ:OPCH – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the fourteen research firms that are covering the stock, MarketBeat Ratings reports. Seven equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 12-month price target among analysts that have covered the stock in the last year is $29.9231.
Several equities research analysts have recently issued reports on OPCH shares. The Goldman Sachs Group assumed coverage on shares of Option Care Health in a research report on Monday, June 8th. They set a “neutral” rating and a $22.00 price objective on the stock. UBS Group reissued a “buy” rating on shares of Option Care Health in a research note on Tuesday, June 16th. Wall Street Zen upgraded shares of Option Care Health from a “hold” rating to a “buy” rating in a report on Saturday, August 1st. Weiss Ratings raised Option Care Health from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday. Finally, Stephens restated an “equal weight” rating and set a $24.00 price objective (down from $30.00) on shares of Option Care Health in a report on Friday, July 17th.
View Our Latest Analysis on OPCH
Institutional Inflows and Outflows
Option Care Health Price Performance
OPCH opened at $23.48 on Thursday. Option Care Health has a 52-week low of $18.01 and a 52-week high of $36.80. The stock has a market capitalization of $3.52 billion, a PE ratio of 17.65, a price-to-earnings-growth ratio of 1.36 and a beta of 0.61. The stock’s 50 day moving average price is $23.03 and its 200-day moving average price is $24.45. The company has a debt-to-equity ratio of 0.91, a quick ratio of 0.98 and a current ratio of 1.47.
Option Care Health (NASDAQ:OPCH – Get Free Report) last announced its earnings results on Wednesday, July 29th. The company reported $0.45 earnings per share for the quarter, beating analysts’ consensus estimates of $0.43 by $0.02. Option Care Health had a net margin of 3.68% and a return on equity of 18.74%. The business had revenue of $1.44 billion during the quarter, compared to the consensus estimate of $1.42 billion. During the same quarter last year, the firm earned $0.41 earnings per share. The business’s revenue for the quarter was up 1.9% on a year-over-year basis. Option Care Health has set its FY 2026 guidance at 1.850-1.920 EPS. On average, equities research analysts predict that Option Care Health will post 1.69 EPS for the current year.
About Option Care Health
Option Care Health, Inc is a provider of home and alternate-site infusion services in the United States. The company works with patients, physicians, hospitals, health plans and pharmaceutical manufacturers to deliver infusion therapy outside traditional hospital settings, including in patients’ homes, ambulatory infusion centers and other outpatient locations.
Its services include pharmacy and nursing support for intravenous and subcutaneous therapies, care coordination, patient education, clinical monitoring and reimbursement assistance.
See Also
- Five stocks we like better than Option Care Health
- Rocket Lab Tackles a Supply Chain Bottleneck as the Stock Hunts for a Bottom. Time to Buy?
- Optical Cable Corporation Is Starting to Get the Market’s Attention
- Oil Above $100 Is Creating a New Opportunity Beyond the Major Producers
- Is Nike’s Index Demotion a Warning or a Buying Opportunity?
Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.
